| Care One At King James | |
| 1040 Route 36, Atlantic Highlands, New Jersey 07716 | |
| (732) 291-3400 | |
| Name | Care One At King James |
|---|---|
| Location | 1040 Route 36, Atlantic Highlands, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 127 |
| Occupancy Rate | 71.81% |
| Medicare ID (CCN) | 315087 |
| Legal Business Name | King James Care Center Of Middletown, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1598764060 |
| Organization Name | KING JAMES CARE CENTER OF MIDDLETOWN, LLC |
| Doing Business As | CARE ONE AT KING JAMES |
| Address | 1040 Highway 36, Middletown, NJ 07748 |
| Phone Number | 732-291-3400 |
News Archive
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Regado Biosciences, Inc, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced enrollment of the first patient in the first Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system.
Milwaukee-based Insurer Assurant Inc. is cutting its workforce in various locations around America ahead of health care reform implementation. The Milwaukee Journal Sentinel reports that 130 jobs in Milwaukee and Plymouth, Minn., will be cut. "The company, which sells health insurance for individuals and small employers as well as short-term policies, faces an onslaught of new federal health care reform regulations, including the requirement that it spend 80% of premiums on medical care.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Regado Biosciences, Inc, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced enrollment of the first patient in the first Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system.
Milwaukee-based Insurer Assurant Inc. is cutting its workforce in various locations around America ahead of health care reform implementation. The Milwaukee Journal Sentinel reports that 130 jobs in Milwaukee and Plymouth, Minn., will be cut. "The company, which sells health insurance for individuals and small employers as well as short-term policies, faces an onslaught of new federal health care reform regulations, including the requirement that it spend 80% of premiums on medical care.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.29 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 18.23 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 53.09 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.26 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.05 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 17.99 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.38 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.31 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.14 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 74.27 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.15 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.56 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 28 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.2 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.67 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 74.75 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.62 | 82.93 |
News Archive
Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age.
Regado Biosciences, Inc, a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced enrollment of the first patient in the first Phase I study of a subcutaneous administration formulation of the REG1 anticoagulation system.
Milwaukee-based Insurer Assurant Inc. is cutting its workforce in various locations around America ahead of health care reform implementation. The Milwaukee Journal Sentinel reports that 130 jobs in Milwaukee and Plymouth, Minn., will be cut. "The company, which sells health insurance for individuals and small employers as well as short-term policies, faces an onslaught of new federal health care reform regulations, including the requirement that it spend 80% of premiums on medical care.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
› Verified 7 days ago
Care One At King James Location: 1040 Route 36, Atlantic Highlands, New Jersey 07716 Phone: (732) 291-3400 |